Dent's disease

Orphanet Journal of Rare Diseases

Volumn 5, Issue 1, 2010, Pages

  Devuyst, Olivier ^a   Thakker, Rajesh V ^b  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHLORIDE CHANNEL; CHLORIDE HYDROGEN EXCHANGER CLC 5; PHOSPHATASE; PHOSPHATIDYLINOSITOL BISPHOSPHATE 5 PHOSPHATASE; UNCLASSIFIED DRUG; CLC 5 CHLORIDE CHANNEL; CLC-5 CHLORIDE CHANNEL; OCRL PROTEIN, HUMAN;

CHROMOSOME XP; CHROMOSOME XQ; CLCN5 GENE; DENT DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; FANCONI RENOTUBULAR SYNDROME; GENE; GENE LOCATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEMATURIA; HUMAN; HYPERCALCIURIA; HYPOPHOSPHATEMIA; KIDNEY CALCIFICATION; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DISORDER; LOWE SYNDROME; MOLECULAR GENETICS; NEPHROLITHIASIS; NONHUMAN; OCRL1 GENE; OSTEOMALACIA; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEINURIA; REVIEW; RICKETS; FEMALE; GENETICS; KIDNEY DISEASE; MALE; MUTATION; PATHOPHYSIOLOGY;

CHLORIDE CHANNELS; DENT DISEASE; FEMALE; HUMANS; HYPERCALCIURIA; KIDNEY DISEASES; MALE; MUTATION; NEPHROCALCINOSIS; NEPHROLITHIASIS; PHOSPHORIC MONOESTER HYDROLASES; PROTEINURIA;

EID: 77957766948     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-5-28     Document Type: Review

References (50)

1. Hypercalcuric rickets associated with renal tubular damage. CE Dent M Friedman, Arch Dis Child 1964 39 240 249 10.1136/adc.39.205.240 14169453
2. Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a micro-deletion involving DXS255 and maps to Xp11.22. MA Pook O Wrong C Wooding AGW Norden TG Feest RV Thakker, Hum Mol Genet 1993 2 2129 2134 10.1093/hmg/2.12.2129 8111383
3. Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies. SJ Scheinman MA Pook C Wooding JT Pang PA Frymoyer RV Thakker, J Clin Invest 1993 91 2351 2357 10.1172/JCI116467 8099916
4. Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. OM Wrong AGW Norden TG Feest, Q J Med 1994 87 473 493
5. A common molecular basis for three inherited kidney stone diseases. SE Lloyd SH Pearce SE Fisher K Steinmeyer B Schwappach SJ Scheinman B Harding A Bolino M Devoto P Goodyer SP Rigden O Wrong TJ Jentsch IW Craig RV Thakker, Nature 1996 379 445 449 10.1038/379445a0 8559248
6. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). SE Lloyd SHS Pearce W Günther H Kawaguchi T Igarashi TJ Jentsch RV Thakker, J Clin Invest 1997 99 967 974 10.1172/JCI119262 9062355
7. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. SJ Scheinman, Kidney Int 1998 53 3 17 10.1046/j.1523-1755. 1998.00718.x 9452994
8. Mutational Analysis of CLC-5, Cofilin and CLC-4 in Patients with Dent's Disease. F Wu AA Reed SE Williams NY Loh JD Lippiat PT Christie O Large A Bettinelli MJ Dillon NP Goldraich B Hoppe K Lhotta C Loirat R Malik D Morel P Kotanko B Roussel D Rubinger C Schrander-Stumpel E Serdaroglu MA Nesbit F Ashcroft RV Thakker, Nephron Physiol 2009 112 53 62 10.1159/000225944
9. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. AE Shrimpton RR Hoopes Jr. SJ Knohl P Hueber AA Reed PT Christie T Igarashi P Lee A Lehman C White DV Milford MR Sanchez R Unwin OM Wrong RV Thakker SJ Scheinman, Nephron Physiol 2009 112 27 36 10.1159/000213506
10. Hypercalciuria in patients with CLCN5 mutations. M Ludwig B Utsch B Balluch S Fründ E Kuwertz-Bröking A Bökenkamp, Pediatr Nephrol 2006 21 1241 1250 10.1007/s00467-006-0172-9 16807762
11. Vitamin A responsive night blindness in Dent's disease. SK Sethi M Ludwig M Kabra P Hari A Bagga, Pediatr Nephrol 2009 24 1765 1770 10.1007/s00467-009- 1198-6 19444483
12. Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. L Copelovitch MA Nash BS Kaplan, Clin J Am Soc Nephrol 2007 2 914 918 10.2215/CJN.00900207 17702731
13. Dent Disease with mutations in OCRL1. RR Hoopes Jr. AE Shrimpton SJ Knohl P Hueber B Hoppe J Matyus A Simckes V Tasic B Toenshoff SF Suchy RL Nussbaum SJ Scheinman, Am J Hum Genet 2005 76 260 267 10.1086/427887 15627218
14. Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. O Scheel AA Zdebik S Lourdel TJ Jentsch, Nature 2005 436 424 427 10.1038/nature03860 16034422
15. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. R Dutzler EB Campbell M Cadene BT Chait R MacKinnon, Nature 2002 415 287 294 10.1038/415287a 11796999
16. Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure. AJ Smith AA Reed NY Loh RV Thakker JD Lippiat, Am J Physiol Renal Physiol 2009 296 390 F397 10.1152/ajprenal.90526.2008 19019917
17. Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. F Wu P Roche PT Christie NY Loh AAC Reed RM Esnouf RV Thakker, Kidney Int 2003 63 1426 1432 10.1046/j.1523-1755. 2003.00859.x 12631358
18. Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines. DH Hryciw Y Wang O Devuyst CA Pollock P Poronnik WB Guggino, J Biol Chem 2003 278 40169 40176 10.1074/jbc.M307890200 12904289
19. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. O Devuyst PT Christie PJ Courtoy R Beauwens RV Thakker, Hum Mol Genet 1999 8 247 257 10.1093/hmg/8.2.247 9931332
20. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. W Günther A Lüchow F Cluzeaud A Vandewalle TJ Jentsch, Proc Natl Acad Sci USA 1998 95 8075 8080 10.1073/pnas.95.14.8075 9653142
21. Megalin and cubilin: multifunctional endocytic receptors. EI Christensen H Birn, Nat Rev Mol Cell Biol 2002 3 256 266 11994745
22. --channel disruption impairs endocytosis in a mouse model for Dent's disease. N Piwon W Gunther M Schwake MR Bösl TJ Jentsch, Nature 2000 408 369 373 10.1038/35042597 11099045
23. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. SS Wang O Devuyst PJ Courtoy T Wang H Wang Y Wang RV Thakker S Guggino WB Guggino, Hum Mol Genet 2000 9 2937 2945 10.1093/hmg/9.20.2937 11115837
24. The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. W Günther N Piwon TJ Jentsch, Pflugers Arch 2003 445 456 462 12548389
25. Impaired acidification in early endosomes of ClC-5 deficient proximal tubule. M Hara-Chikuma Y Wang SE Guggino WB Guggino AS Verkman, Biochem Biophys Res Commun 2005 329 941 946 10.1016/j.bbrc.2005.02.060 15752747
26. Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. G Novarino S Weinert G Rickheit TJ Jentsch, Science 2010 328 1398 1401 10.1126/science.1188070 20430975
27. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. EI Christensen O Devuyst G Dom R Nielsen P Van der Smissen P Verroust M Leruth WB Guggino PJ Courtoy, Proc Natl Acad Sci USA 2003 100 8472 8477 10.1073/pnas.1432873100 12815097
28. Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. TJ Jentsch, J Physiol 2007 578 633 640 10.1113/jphysiol.2006.124719 17110406
29. Type III carbonic anhydrase: A novel renal isoform that plays a role in proximal tubule dysfunction. P Gailly F Jouret D Martin JP Cosyns T Nishita C Antignac TE Willnow PJ Courtoy SJ Scheinman EI Christensen O Devuyst, Kidney Int 2008 74 52 61 10.1038/sj.ki.5002794 18322545
30. Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells. R Nielsen PJ Courtoy C Jacobsen G Dom W Rezende Lima M Jadot TE Willnow O Devuyst EI Christensen, Proc Natl Acad Sci USA 2007 104 5407 5412 10.1073/pnas.0700330104 17369355
31. Nephrolithiasis related to inborn metabolic diseases. P Cochat V Pichault J Bacchetta L Dubourg JF Sabot C Saban M Daudon A Liutkus, Pediatr Nephrol 2010 25 415 424 10.1007/s00467-008-1085-6 19156444
32. Hypertonicity increases ClC-5 expression in mouse medullary thick ascending limb cells. PCT Pham O Devuyst PTT Pham N Matsumoto RNG Shih OD Jo N Yanagawa AM Sun, Am J Physiol Renal Physiol 2004 287 747 F752 10.1152/ajprenal.00229.2003 15161605
33. Genetics of hypercalciuric stone forming diseases. O Devuyst Y Pirson, Kidney Int 2007 72 1065 1072 10.1038/sj.ki.5002441 17687260
34. Isolated hypercalciuria with mutation in CLCN5: Relevance to idiopathic hypercalciuria. SJ Scheinman JPD Cox SE Lloyd SHS Pearce PV Salenger RR Hoopers DA Bushinsky O Wrong Jr. Asplin CB Langman AGW Norden RV Thakker, Kidney Int 2000 57 232 239 10.1046/j.1523-1755.2000.00774.x 10620204
35. Calcium phosphate and calcium oxalate crystal handling is dependent upon CLC-5 expression in mouse collecting duct cells. JA Sayer G Carr NL Simmons, Biochim Biophys Acta 2004 1689 83 90 15158917
36. Tissue distribution and subcellular localization of the ClC-5 chloride channel in rat intestinal cells. A Vandewalle F Cluzeaud KC Peng M Bens A Lüchow W Günther TJ Jentsch, Am J Physiol Cell Physiol 2001 280 373 C381 11208533
37. The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces an euthyroid goiter in the mouse. MF Vanden Hove K Croizet-Berger F Jouret SE Guggino WB Guggino O Devuyst PJ Courtoy, Endocrinology 2006 147 1287 1296 10.1210/en.2005-1149 16306076
38. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. AM Leahey LR Charnas RL Nussbaum, Hum Mol Genet 1993 2 461 463 10.1093/hmg/2.4.461 8504307
39. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. X Zhang PA Hartz E Philip LC Racusen PW Majerus, J Biol Chem 1998 273 1574 1582 10.1074/jbc.273.3.1574 9430698
40. Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. AJ Ungewickell PW Majerus, Proc Natl Acad Sci USA 1999 96 13342 13344 10.1073/pnas.96.23.13342 10557322
41. Structure and function of the Lowe syndrome protein OCRL1. M Lowe, Traffic 2005 6 711 719 10.1111/j.1600-0854.2005.00311.x 16101675
42. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. KS Erdmann Y Mao HJ McCrea R Zoncu S Lee S Paradise J Modregger D Biemesderfer D Toomre P De Camilli, Dev Cell 2007 13 377 390 10.1016/j.devcel.2007.08.004 17765681
43. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. PA Jänne SF Suchy D Bernard M MacDonald J Crawley A Grinberg A Wynshaw-Boris H Westphal RL Nussbaum, J Clin Invest 1998 101 2042 2053 10.1172/JCI2414 9593760
44. Dent's disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg? Y Frishberg D Dinour R Belostotsky R Becker-Cohen C Rinat S Feinstein P Navon-Elkan E Ben-Shalom, Pediatr Nephrol 2009 24 2369 2373 10.1007/s00467-009-1299-2 19806368
45. +-ATPase without ultrastructural changes in kidneys of Dent's disease patients. P Moulin T Igarashi P Van Der Smissen JP Cosyns P Verroust O Wrong RV Thakker SJ Scheinman PJ Courtoy O Devuyst, Kidney Int 2003 63 1285 1295 10.1046/j.1523-1755.2003. 00851.x 12631345
46. Fanconi syndrome. T Igarashi, Pediatric Nephrology Springer-Verlag, Berlin Heidelberg, Avner ED, Harmon WE, Niaudet P, Yoshikawa N, 6 2009 1039 1067 19159957
47. X-linked recessive nephrolithiasis with renal failure. PA Frymoyer SJ Scheinman PB Dunham DB Jones P Hueber ET Schroeder, N Engl J Med 1991 325 681 686 10.1056/NEJM199109053251003 1908057
48. Responsiveness of hypercalciuria to thiazide in Dent's disease. KA Raja S Schurman RG D'mello D Blowey P Goodyer S Van Why RJ Ploutz-Snyder J Asplin SJ Scheinman, J Am Soc Nephrol 2002 13 2938 2944 10.1097/01.ASN.0000036869.82685.F6 12444212
49. Effect of hydrochlorothiazide on urinary calcium excretion in Dent disease: an uncontrolled trial. A Blanchard R Vargas-Poussou S Peyrard A Mogenet V Baudouin B Boudailliez M Charbit G Deschesnes N Ezzhair C Loirat MA Macher P Niaudet M Azizi, Am J Kidney Dis 2008 52 1084 1095 10.1053/j.ajkd.2008.08.021 18976849
50. High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. V Cebotaru S Kaul O Devuyst H Cai L Racusen WB Guggino SE Guggino, Kidney Int 2005 68 642 652 10.1111/j.1523-1755. 2005.00442.x 16014041